Correspondence 0001437749-26-012155 from BIOLARGO, INC. (BLGO)
BIOLARGO, INC.
Date: April 13, 2026 · CIK: 0000880242 · Accession: 0001437749-26-012155
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294947
Letter
blgo20260411_corresp.htm
BioLargo, Inc.
14921 Chestnut St.
Westminster, CA 92683
Telephone: 888.400.2863
April 13, 2026
U.S. Securities & Exchange Commission
Division of Corporation Finance
100 F. Street NE
Washington, D.C. 20549
Re: BioLargo, Inc.
Registration Statement on Form S-1
Filed April 9, 2026
File No. 333-294947
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioLargo, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1, file number 333-294947 (the “Registration Statement”), as amended, so that it may become effective at 5:00 p.m. Eastern Time on April 15, 2026, or as soon as practicable thereafter.
The Registrant hereby acknowledges that:
(i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(iii) the Registrant may not assert comments of the Commission or the staff and the declaration of effectiveness of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We confirm that we are aware of our responsibilities under the Securities Act and the Securities Exchange Act as they relate to the public offering of securities specified in the Registration Statement.
We respectfully request that a copy of the written order from the Commission verifying the effective time and date of such Registration Statement be sent via facsimile to 949-234-6265.
Very truly yours,
/s/Dennis P. Calvert
Show Raw Text
CORRESP 1 filename1.htm blgo20260411_corresp.htm BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683 Telephone: 888.400.2863 April 13, 2026 U.S. Securities & Exchange Commission Division of Corporation Finance 100 F. Street NE Washington, D.C. 20549 Re: BioLargo, Inc. Registration Statement on Form S-1 Filed April 9, 2026 File No. 333-294947 REQUEST FOR ACCELERATION OF EFFECTIVENESS Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioLargo, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1, file number 333-294947 (the “Registration Statement”), as amended, so that it may become effective at 5:00 p.m. Eastern Time on April 15, 2026, or as soon as practicable thereafter. The Registrant hereby acknowledges that: (i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and (iii) the Registrant may not assert comments of the Commission or the staff and the declaration of effectiveness of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We confirm that we are aware of our responsibilities under the Securities Act and the Securities Exchange Act as they relate to the public offering of securities specified in the Registration Statement. We respectfully request that a copy of the written order from the Commission verifying the effective time and date of such Registration Statement be sent via facsimile to 949-234-6265. Very truly yours, /s/Dennis P. Calvert Dennis P. Calvert President BioLargo, Inc. cc: Gilbert Bradshaw, Esq. gbradshaw@securitieslegal.com